Liberty Capital Management, Inc. Pfizer Inc Transaction History

Liberty Capital Management, Inc.

$404 Million
Q1 2024

A detailed history of Liberty Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Liberty Capital Management, Inc. holds 7,208 shares of PFE stock, worth $201,319. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,208

Previous 7,339 1.78%

Holding current value

$201,319

Previous $211,000 5.21%

% of portfolio

0.05%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $3,391 - $3,894	-131 Reduced 1.78%	7,208 $200,000
Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $6,262 - $8,175	-150 Reduced 2.0%	7,339 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $327,718 - $400,062	7,489 New	7,489 $328,000
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $13,563 - $15,296	-405 Reduced 5.0%	7,690 $279,000
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $133 - $170	4 Added 0.05%	8,095 $298,000

Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $34,463 - $49,240	-1,275 Reduced 13.61%	8,091 $264,000
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $3,292 - $3,736	-100 Reduced 1.06%	9,366 $367,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $4,256 - $5,519	-131 Reduced 1.37%	9,466 $340,000
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $13,125 - $14,420	-350 Reduced 3.52%	9,597 $408,000
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $8,540 - $9,736	-222 Reduced 2.18%	9,947 $434,000
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $44,811 - $54,353	-1,300 Reduced 11.33%	10,169 $448,000
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $3,510 - $4,072	-110 Reduced 0.95%	11,469 $407,000
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $358,949 - $395,422	11,579	11,579 $422,000

Others Institutions Holding PFE

# of Institutions

3,162

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Capital Management, Inc. with notifications on news.

Account

Liberty Capital Management, Inc. Pfizer Inc Transaction History